Your browser doesn't support javascript.
loading
Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial.
Lublin, Fred; Miller, David H; Freedman, Mark S; Cree, Bruce A C; Wolinsky, Jerry S; Weiner, Howard; Lubetzki, Catherine; Hartung, Hans-Peter; Montalban, Xavier; Uitdehaag, Bernard M J; Merschhemke, Martin; Li, Bingbing; Putzki, Norman; Liu, Fonda C; Häring, Dieter A; Kappos, Ludwig.
Affiliation
  • Lublin F; The Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: fred.lublin@mssm.edu.
  • Miller DH; Queen Square MS Centre, UCL Institute of Neurology, London, UK.
  • Freedman MS; The Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada.
  • Cree BAC; Multiple Sclerosis Center, University of California San Francisco, CA, USA.
  • Wolinsky JS; University of Texas Health Science Center at Houston, Houston, TX, USA.
  • Weiner H; Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Lubetzki C; University Paris 6, Salpêtrière Hospital APHP, Center of Clinical Investigation, Paris, France.
  • Hartung HP; Department of Neurology, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany.
  • Montalban X; Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Uitdehaag BMJ; VU University Medical Center, Amsterdam, Netherlands.
  • Merschhemke M; Novartis Pharma AG, Basel, Switzerland.
  • Li B; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Putzki N; Novartis Pharma AG, Basel, Switzerland.
  • Liu FC; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Häring DA; Novartis Pharma AG, Basel, Switzerland.
  • Kappos L; Departments of Medicine, Clinical Research, Biomedicine and Biomedical Engineering, University Hospital, University of Basel, Switzerland.
Lancet ; 387(10023): 1075-1084, 2016 Mar 12.
Article in En | MEDLINE | ID: mdl-26827074
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Sclerosis, Chronic Progressive / Fingolimod Hydrochloride / Immunosuppressive Agents Type of study: Clinical_trials / Guideline Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Lancet Year: 2016 Document type: Article Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Sclerosis, Chronic Progressive / Fingolimod Hydrochloride / Immunosuppressive Agents Type of study: Clinical_trials / Guideline Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Lancet Year: 2016 Document type: Article Country of publication: United kingdom